| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2025 ( Subtotal = $1,463,797 ) |
| 2025 | 2025 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01EY026944 | Therapeutic control of HSK by CD80 | 000 | 9 | NIH | 12/4/2024 | $417,500 |
| 2025 | 2025 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01HL168296 | Regulatory T cell augmentation by a long noncoding RNA: mechanisms and therapeutic applications in myocarditis | 000 | 2 | NIH | 11/26/2024 | $417,500 |
| 2025 | 2025 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01CA298988 | Assessing, Optimizing, and Delivering Surgical Feedback with AI for Benign Urological Robotic Surgeries | 000 | 1 | NIH | 11/28/2024 | $596,179 |
| 2025 | 2025 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | F31CA278582 | The non-canonical Collagen I-DDR1 signaling regulating protein synthesis during metastasis | 000 | 2 | NIH | 11/19/2024 | $41,294 |
| 2025 | 2025 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01HL160860 | A hypercholesterolemia-induced immunometabolite in atherosclerosis | 000 | 4 | NIH | 11/15/2024 | $534,028 |
| 2025 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01CA268055 | NPEPPS is a novel and druggable determinant of chemotherapy resistance in bladder cancer | 001 | 3 | NIH | 11/14/2024 | $8,804 |
| 2025 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01CA268055 | NPEPPS is a novel and druggable determinant of chemotherapy resistance in bladder cancer | 000 | 3 | NIH | 10/18/2024 | $0 |
| 2025 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | U3REP220672 | CSMC Special Pathogens Regional Emerging Special Pathogen Treatment Center Cooperative Agreement Year 2 | 01 | 3 | ASPR | 12/3/2024 | $0 |
| 2025 | 2023 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R35GM131905 | Data-driven drug discovery: investigating the molecular mechanisms of safety and efficacy | 000 | 6 | NIH | 11/7/2024 | $0 |
| 2025 | 2023 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01HL156818 | SSFP Cardiovascular MR Imaging on 3.0T Using Unified-Coil Local Shimming | 000 | 3 | NIH | 10/31/2024 | -$657,292 |
| 2025 | 2023 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R00HL141702 | Metabolic Rewiring of the Heart Through Reductive Carboxylation | 000 | 6 | NIH | 10/28/2024 | -$54,545 |
| 2025 | 2023 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01AI148073 | Role of PTPN2 in rheumatoid arthritis | 001 | 5 | NIH | 10/22/2024 | $336,471 |
| 2025 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | K08HL141446 | The role of type 1 interferon in regulating alloimmune responses to transfused red blood cells | 000 | 5 | NIH | 11/21/2024 | $0 |
| 2025 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01AI134987 | Monocyte Production by Bone Marrow Progenitors | 000 | 5 | NIH | 11/22/2024 | $0 |
| 2025 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | P01HL108793 | Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD) | 000 | 10 | NIH | 12/5/2024 | -$129,335 |
| 2025 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01HL147570 | Calcium Regulation in Heart Failure with Preserved versus Reduced Ejection Fraction | 000 | 4 | NIH | 10/28/2024 | $0 |
| 2025 | 2022 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01AI099009 | Regulation of cytosolic pattern recognition receptor signaling in macrophages | 000 | 10 | NIH | 10/21/2024 | -$35,026 |
| 2025 | 2021 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01CA218356 | A blood test to identify prostate cancer patients at risk for visceral metastasis | 000 | 5 | NIH | 11/27/2024 | -$6,348 |
| 2025 | 2019 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | P01CA098912 | Prostate Cancer Bone Metastasis Biology and Targeting | 000 | 15 | NIH | 10/1/2024 | -$5,433 |
|
| Issue Date FY: 2024 ( Subtotal = $103,774,188 ) (Continued on the next page) |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01CA280081 | A Comparative Study of Risk Factors for Men with and without Prostate Cancer at the VA Medical Center in Durham | 000 | 2 | NIH | 7/25/2024 | $644,974 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01CA276448 | Role of AMPK in melanoma brain metastasis | 003 | 3 | NIH | 4/16/2024 | $33,551 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01CA276448 | Role of AMPK in melanoma brain metastasis | 002 | 3 | NIH | 1/5/2024 | $603,881 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R00HL157421 | Deep Learning Assessment of the Right Ventricle: Function, Etiology, and Prognosis | 000 | 4 | NIH | 1/22/2024 | $248,979 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | K99AG084864 | Establishing reactive astrocyte memory as a risk factor for aging-related neurodegenerative disease | 000 | 1 | NIH | 7/26/2024 | $107,865 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01HL172990 | Targeting WNT7A Signaling in Pulmonary Fibrosis | 000 | 1 | NIH | 7/23/2024 | $787,266 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01HD113693 | Functional Genomics Across an Ethnically and Racially Diverse Endometriosis Population | 001 | 1 | NIH | 7/29/2024 | -$607,396 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01HD113693 | Functional Genomics Across an Ethnically and Racially Diverse Endometriosis Population | 000 | 1 | NIH | 12/27/2023 | $607,397 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01AI175101 | Regulation of cellular functions and innate immunity by interleukin-1alpha | 001 | 1 | NIH | 9/4/2024 | $60,250 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01AI175101 | Regulation of cellular functions and innate immunity by interleukin-1alpha | 000 | 1 | NIH | 11/3/2023 | $542,249 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01LM014572 | Knowledge-guided automated machine learning methods for modeling the interaction of HIV with addictive drugs | 000 | 1 | NIH | 6/28/2024 | $508,201 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01AI164519 | ACE and myeloid cell metabolism | 002 | 3 | NIH | 7/25/2024 | $338,801 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01AI164519 | ACE and myeloid cell metabolism | 001 | 3 | NIH | 5/24/2024 | $56,043 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01AI164519 | ACE and myeloid cell metabolism | 000 | 3 | NIH | 1/17/2024 | $504,383 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01CA280060 | Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer | 001 | 2 | NIH | 8/19/2024 | $657,403 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01HL175875 | AI-enabled characterization of fibrocalcific aortic valve disease and inflammation from CT Angiography: Patient-specific outcome prediction | 000 | 1 | NIH | 9/1/2024 | $810,650 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01DK130851 | Evaluating environmental control (AVOID) and inhibitory control (RESIST) strategies to improve weight management outcomes | 001 | 3 | NIH | 5/16/2024 | $42,950 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01DK130851 | Evaluating environmental control (AVOID) and inhibitory control (RESIST) strategies to improve weight management outcomes | 000 | 3 | NIH | 1/25/2024 | $644,243 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01HL160860 | A hypercholesterolemia-induced immunometabolite in atherosclerosis | 001 | 3 | NIH | 6/26/2024 | $48,627 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01HL160860 | A hypercholesterolemia-induced immunometabolite in atherosclerosis | 000 | 3 | NIH | 11/16/2023 | $547,071 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01CA283313 | Mechanistic studies of hirsutinolides and azetidine based small molecule inhibitors of STAT3 | 001 | 1 | NIH | 8/19/2024 | $128,902 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01CA283313 | Mechanistic studies of hirsutinolides and azetidine based small molecule inhibitors of STAT3 | 000 | 1 | NIH | 3/26/2024 | $703,595 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01CA292654 | A translational study of a synthetic lethality interaction of CD105 and androgen receptor signaling axis for castration-resistant prostate cancer patients | 000 | 1 | NIH | 6/21/2024 | $553,550 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01DK080834 | Inhibition of an Apical cAMP/cGMP Transporter (MRP4) in the Gut Induces Diarrhea | 000 | 17 | NIH | 5/21/2024 | $606,584 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01NS131782 | Defining the role of Tox3 in congenital cerebellar hypoplasia and ataxia | 001 | 1 | NIH | 8/14/2024 | $44,559 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01NS131782 | Defining the role of Tox3 in congenital cerebellar hypoplasia and ataxia | 000 | 1 | NIH | 7/8/2024 | $462,744 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01MH136492 | SARS-CoV-2 and Social Determinants of Health Impact on Inflammation Associated Depression Risk (SSIDR) | 000 | 1 | NIH | 7/3/2024 | $833,123 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | K08HS029534 | Detecting and characterizing diagnostic errors among high-risk patients discharged from the emergency department | 001 | 1 | AHRQ | 8/9/2024 | $0 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01HL155346 | Exosome Therapeutics to Dissect HFpEF Mechanisms | 000 | 4 | NIH | 6/24/2024 | $817,741 |
|